Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: A national cohort of 147 987 singleton pregnancies

Ultrasound in Obstetrics and Gynecology

Volumn 47, Issue 1, 2016, Pages 38-44

  Wulff, C B ^a,b   Gerds, T A ^b   Rode, L ^a,c   Ekelund, C K ^a   Petersen, O B ^d   Tabor, A ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

amniocentesis; chorionic villus sampling; combined first trimester screening; fetal loss; invasive prenatal testing; miscarriage; procedure related risk; stillbirth

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PAPPA1 PROTEIN, HUMAN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ABORTION, SPONTANEOUS; ADULT; AMNIOCENTESIS; CASE CONTROL STUDY; CHORION VILLUS SAMPLING; COHORT ANALYSIS; DENMARK; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; METABOLISM; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK; STATISTICS AND NUMERICAL DATA; STILLBIRTH; YOUNG ADULT;

ABORTION, SPONTANEOUS; ADULT; AMNIOCENTESIS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHORIONIC VILLI SAMPLING; COHORT STUDIES; DENMARK; DOWN SYNDROME; FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK; STILLBIRTH; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 84953449783     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.15820     Document Type: Article

References (27)

1. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B,. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; 1: 1287-1293.
2. Tabor A, Alfirevic Z,. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010; 27: 1-7.
3. Ekelund CK, Jorgensen FS, Petersen OB, Sundberg K, Tabor A,. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ 2008; 337: a2547.
4. Hui L, Muggli EE, Halliday JL,. Population-based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38 years of state-wide data. BJOG 2015. DOI: 10.1111/1471-0528.13488. [Epub ahead of print]
5. Nicolaides KH,. Turning the pyramid of prenatal care. Fetal Diagn Ther 2011; 29: 183-196.
6. Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F,. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 16-26.
7. Dugoff L, Cuckle HS, Hobbins JC, Malone FD, Belfort MA, Nyberg DA, Comstock CH, Saade GR, Eddleman KA, Dar P, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME,; FaSTER Trial Research Consortium. Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers. Am J Obstet Gynecol 2008; 199: 290-296.
8. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M,. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320: 1708-1712.
9. Spencer K, Cowans NJ, Avgidou K, Nicolaides KH,. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Ultrasound Obstet Gynecol 2006; 28: 637-643.
10. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K,. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-869.
11. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH,. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999; 13: 231-237.
12. Szabo J, Gellen J, Szemere G,. First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age. Ultrasound Obstet Gynecol 1995; 5: 161-163.
13. Tul N, Spencer K, Noble P, Chan C, Nicolaides KH,. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 1999; 19: 1035-1042.
14. Ekelund CK, Petersen OB, Jorgensen FS, Kjaergaard S, Larsen T, Olesen AW, Skibsted L, Skovbo P, Sommer S, Sperling L, Stavnstrup B, Størup B, Zingenberg H, Uldbjerg N, Miltoft CB, Noergaard L, Wulff CB, Tabor A,; Danish Fetal Medicine Research Group The Danish Fetal Medicine Database: establishment, organization and quality assessment of the first trimester screening program for trisomy 21 in Denmark 2008-2012. Acta Obstet Gynecol Scand 2015; 94: 577-583.
15. Robinson HP, Fleming JE,. A critical evaluation of sonar crown-rump length measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
16. Austin PC,. An Introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011; 46: 399-424.
17. Lunceford JK, Davidian M,. Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med 2004; 23: 2937-2960.
18. Rosenbaum PR, Rubin DB,. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41-55.
19. Van Houwelingen HC,. Dynamic prediction by landmarking in event history analysis. Scand J Stat 2007; 34: 70-85.
20. Hastie TJ, Tibshirani RJ,. Generalized Additive Models. CRC Press: London, 1990.
21. Greenland S, Robins JM,. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985; 41: 55-68.
22. Akolekar R, Bower S, Flack N, Bilardo CM, Nicolaides KH,. Prediction of miscarriage and stillbirth at 11-13 weeks and the contribution of chorionic villus sampling. Prenat Diagn 2011; 31: 38-45.
23. Mujezinovic F, Alfirevic Z,. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007; 110: 687-694.
24. Nicolaides K, Brizot ML, Patel F, Snijders R,. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation. Lancet 1994; 344: 435-439.
25. Halliday JL, Lumley J, Sheffield LJ, Robinson HP, Renou P, Carlin JB,. Importance of complete follow-up of spontaneous fetal loss after amniocentesis and chorion villus sampling. Lancet 1992; 340: 886-890.
26. Tabor A, Vestergaard CH, Lidegaard O,. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol 2009; 34: 19-24.
27. Wijnberger LD, van der Schouw YT, Christiaens GC,. Learning in medicine: chorionic villus sampling. Prenat Diagn 2000; 20: 241-246.